Physician profile
James M Guiler
NPI 1104816388
$25,076.76
in general payments reported to CMS, 2019-2025
31 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,429 · 2020: $293 · 2021: $20K · 2022: $983 · 2023: $883 · 2024: $412 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,448 · Gift: $100 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,447.63 |
| Gift | $100.00 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,382.87 | 2019-2021 | |
| Caldera Medical, INC | $2,723.91 | 2019-2023 | Desara |
| Axonics, INC. | $853.08 | 2020-2024 | Axonics |
| Sumitomo Pharma America, INC. | $548.30 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $347.55 | 2019-2023 | |
| Astellas Pharma US INC | $274.24 | 2019-2023 | Myrbetriq |
| Ascend Therapeutics US, LLC | $264.05 | 2019-2022 | |
| Gynesonics, INC. | $212.26 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $152.98 | 2022-2024 | |
| Myovant Sciences INC. | $139.42 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $139.36 | 2019-2022 | |
| Avion Pharmaceuticals | $116.96 | 2021-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $116.68 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.77 | 2019-2020 | |
| Urovant Sciences INC | $77.97 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $77.08 | 2019-2022 | |
| Allergan, INC. | $63.14 | 2019-2021 | |
| Medtronic, INC. | $60.23 | 2022-2025 | Altaviva, Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $58.14 | 2021 | |
| Hologic Sales and Service, LLC | $51.80 | 2019-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Lupin INC. | $49.38 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $45.52 | 2021 | |
| Coloplast Corp | $42.69 | 2019-2023 | Altis |
| Millicent US INC | $34.04 | 2025 | Intrarosa, Femlyv |
| Exact Sciences Corporation | $28.49 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $28.02 | 2022-2023 | Wegovy |
| Idorsia Pharmaceuticals US INC | $27.87 | 2023 | Quviviq |
| Ardelyx, INC. | $21.88 | 2024 | Ibsrela |
| Glaxosmithkline, LLC. | $17.27 | 2025 | Pediarix, Bexsero |
| Evofem Biosciences, INC. | $12.29 | 2020 | |
| Boston Scientific Corporation | $11.52 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Guiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.